Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340026 · ClinicalTrials.gov registry record · NA
Cerebral Palsy Early Mobility Training
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02340026 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 42 participants.
The verdict
NCT02340026, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal treatment duration of a novel early mobility training program (dynamic supported mobility, DSM) between 6 to 24 weeks of treatment; and to evaluate the clinical futility of this intervention compared to current rehabilitation practice.
Interventions
- OTHER Conventional Therapy
- OTHER Dynamic Supported Mobility
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-01-15 |
| Est. Completion | 2020-07-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02340026
The ClinicalTrials.gov registry entry for NCT02340026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional Therapy is the first listed.
NCT02340026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02340026 about?
NCT02340026 is a clinical study titled "Cerebral Palsy Early Mobility Training". The purpose of this study is to determine the optimal treatment duration of a novel early mobility training program (dynamic supported mobility, DSM) between 6 to 24 weeks of treatment; and to evaluate the clinical futility of this intervention compared to current rehabilitation practice.
What is the current status of trial NCT02340026?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2015-01-15. Estimated completion is 2020-07-13.
What interventions are being tested in trial NCT02340026?
The interventions under investigation include: Conventional Therapy (OTHER), Dynamic Supported Mobility (OTHER).
Who is sponsoring clinical trial NCT02340026?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.